-
Novel Mouse Avatars Could Advance Personalized Medicine For Cancer
Clinical Research News | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.
May 3, 2023
-
Ardy Arianpour on Seqster’s Mission, Growth, and Pharma Tipping Point
Clinical Research News | When Seqster was first founded in 2016, co-founder Ardy Arianpour had a lot of experience in next-gen sequencing and a vision for how consumers could control their health information. Seqster is more than a company, Arianpour insists to host, Deborah Borfitz, in the latest Scope of Things podcast. “This is a movement.”
May 2, 2023
-
Patient Platform from Greenphire, Medidata AI Platform, More
Clinical Research News | Greenphire launches a new patient-facing digital platform, Medidata’s AI Intelligent Trials platform will support Launch Therapeutics, gold-based compounds target “superbugs”, The University of Chicago Medicine Comprehensive Cancer Center has been named the newest member institution of the National Comprehensive Cancer Network Agency, and more.
Apr 27, 2023
-
PEACE Study Offers New Clues About How Cancer Resists Treatment
Clinical Research News | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.
Apr 26, 2023